[ad_1]
The number of reported coronavirus cases worldwide just exceeded 30 million. World Health Organization He says “Alarming transmission rates” can be seen again in Europe, bringing new urgency to the global search for a vaccine.
There are 36 vaccines for COVID-19 currently in human trials, according to the WHO.
In a rare look inside a Wockhardt UK facility in Britain, CBS News foreign correspondent Holly Williams saw how a vaccine would be produced for widespread use.
At the facility, a sterile production line could mass produce a vaccine in a few weeks. Right now, they are training staff by filling glass vials with water.
They could start filling vials with a vaccine starting in November, perhaps even before a vaccine is approved. That’s because as soon as they get final approval, they want to send it out to the public.
“These are unprecedented times and require unprecedented initiatives,” said Wockhardt UK Managing Director Ravi Limaye.
Limaye told Williams that his facility can produce up to 240 million doses of a new vaccine in one year.
But if the vaccine they start producing is not approved for safety, they will simply have to throw it away.
When asked if it is a gamble to start packaging millions of doses of a vaccine before it has final approval, Limaye said: “I will not say it is a gamble. I would say it is an investment in public health.”
the Oxford vaccinepossibly the leader in the race to stop the new virus despite a recent hiatus in its testing, it will likely come on installation.
The United States government has given more than $ 1 billion to its backing pharmaceutical company, AstraZeneca, to secure at least 300 million doses.
The world’s largest vaccine manufacturer, based in India, warned this week that production is not increasing fast enough and that it could take until 2024 to produce enough doses of vaccine to cover the entire world.
